UMR hosts DC briefing on Human Genome Project

Last week, United for Medical Research (UMR), a consortium of leading research institutions, patient and health advocates, and private industry in support of NIH (National Institutes of Health), hosted a panel discussion on the impact of genomics on the U.S. economy. Several New England Council members are also members of UMR, including Thermo Fisher Scientific, Partners HealthCare, Boston University, and Harvard University.

The briefing featured remarks from NIH Director Dr. Francis Collins and the panelists discussed the progress of the Human Genome Project. . At the briefing, UMR and Battelle released an updated report, “The Impact of Genomics on the U.S. Economy,” a follow-up to the original May 2011 report. The original report detailed the impact of the federal investment in the Human Genome Project between 1988 and 2010. The update highlights the significant dividends leveraged from the government’s investment in genomics through 2012.

The panel discussion focused on how the new genomics industry has continued to thrive, improving public health, fueling economic output, creating jobs and personal income, and other social benefits despite the economic recession. Panelists included  Eric Green, Director of the National Human Genome Research Institute; Martin Grueber, co-author  of the Human Genome Report; Greg Lucier, Chairman and CEO of Life Technologies; Carrie Wolinetz, President of United for Medical Research; Ada Hamosh, Professor at Johns Hopkins University School of Medicine, and Ian Lock; a cancer survivor.

img_side
mask_sidebar
Recently from the Blog

MassDevelopment Issues Bond for New Perkins School Building and Dorm

11/19/2020 | Read Post

South Shore Health Names New Vice Chair of Emergency Medicine and Urgent Care

11/19/2020 | Read Post

In the News

NEC Elects Six Respected Regional Business Leaders to Board of Directors

09/28/2020 | Read Press Release

NEC Announces 2020 New Englanders of the Year

08/25/2020 | Read Press Release